Marek's Disease Virus-Encoded MicroRNA 155 Ortholog Critical for the Induction of Lymphomas Is Not Essential for the Proliferation of Transformed Cell Lines.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 09 2019
Historique:
received: 30 04 2019
accepted: 05 06 2019
pubmed: 14 6 2019
medline: 3 6 2020
entrez: 14 6 2019
Statut: epublish

Résumé

MicroRNAs (miRNAs) are small noncoding RNAs with profound regulatory roles in many areas of biology, including cancer. MicroRNA 155 (miR-155), one of the extensively studied multifunctional miRNAs, is important in several human malignancies such as diffuse large B cell lymphoma and chronic lymphocytic leukemia. Moreover, miR-155 orthologs KSHV-miR-K12-11 and MDV-miR-M4, encoded by Kaposi's sarcoma-associated herpesvirus (KSHV) and Marek's disease virus (MDV), respectively, are also involved in oncogenesis. In MDV-induced T-cell lymphomas and in lymphoblastoid cell lines derived from them, MDV-miR-M4 is highly expressed. Using excellent disease models of infection in natural avian hosts, we showed previously that MDV-miR-M4 is critical for the induction of T-cell lymphomas as mutant viruses with precise deletions were significantly compromised in their oncogenicity. However, those studies did not elucidate whether continued expression of MDV-miR-M4 is essential for maintaining the transformed phenotype of tumor cells. Here using an

Identifiants

pubmed: 31189706
pii: JVI.00713-19
doi: 10.1128/JVI.00713-19
pmc: PMC6694823
pii:
doi:

Substances chimiques

MicroRNAs 0
RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007032
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R007632/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R007896/1
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Zhang et al.

Références

Proc Natl Acad Sci U S A. 2000 May 23;97(11):6091-6
pubmed: 10823954
J Virol. 2000 Sep;74(17):7980-8
pubmed: 10933706
Genes Chromosomes Cancer. 2003 May;37(1):20-8
pubmed: 12661002
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11815-20
pubmed: 15289599
J Virol. 2004 Dec;78(23):13376-80
pubmed: 15542691
Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3627-32
pubmed: 15738415
J Pathol. 2005 Oct;207(2):243-9
pubmed: 16041695
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1687-92
pubmed: 16446447
Nat Genet. 2006 Jun;38 Suppl:S25-30
pubmed: 16736021
J Virol. 2006 Sep;80(17):8778-86
pubmed: 16912324
J Virol. 2007 Dec;81(23):12836-45
pubmed: 17881434
Nature. 2007 Dec 13;450(7172):1096-9
pubmed: 18075594
J Virol. 2008 Apr;82(8):4007-15
pubmed: 18256158
J Virol. 2008 Dec;82(24):12213-20
pubmed: 18842708
J Virol. 2009 Jan;83(1):489-92
pubmed: 18945769
J Gen Virol. 2009 Jul;90(Pt 7):1551-9
pubmed: 19297609
Trends Microbiol. 2009 Dec;17(12):544-53
pubmed: 19828316
Annu Rev Microbiol. 2010;64:123-41
pubmed: 20477536
J Virol. 2010 Nov;84(22):11670-8
pubmed: 20844043
Virology. 2011 Mar 15;411(2):325-43
pubmed: 21277611
PLoS Pathog. 2011 Feb;7(2):e1001305
pubmed: 21383974
PLoS Pathog. 2011 May;7(5):e1001337
pubmed: 21573129
Biochim Biophys Acta. 2011 Nov-Dec;1809(11-12):654-9
pubmed: 21683170
PLoS Pathog. 2011 Oct;7(10):e1002333
pubmed: 22046133
J Virol. 2012 Feb;86(3):1683-95
pubmed: 22090140
PLoS Pathog. 2012 Dec;8(12):e1003018
pubmed: 23308061
Immunol Rev. 2013 May;253(1):167-84
pubmed: 23550646
J Virol. 2013 Nov;87(21):11908-11
pubmed: 23966392
Virology. 2014 Jan 5;448:55-64
pubmed: 24314636
MBio. 2014 Jan 21;5(1):e01060-13
pubmed: 24449754
Viruses. 2014 Mar 21;6(3):1379-94
pubmed: 24662606
J Gen Virol. 2017 Apr;98(4):810-820
pubmed: 28113043
J Gen Virol. 2017 Apr;98(4):779-790
pubmed: 28475033
Front Microbiol. 2017 Jun 26;8:1169
pubmed: 28694799
Viruses. 2018 May 24;10(6):
pubmed: 29794970
J Virol. 2018 Sep 12;92(19):null
pubmed: 30021904
Viruses. 2019 Apr 26;11(5):null
pubmed: 31027375
Biken J. 1974 Sep;17(3):105-16
pubmed: 4616680

Auteurs

Yaoyao Zhang (Y)

The Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Guildford, Surrey, United Kingdom.
School of Animal Science and Technology, Guangxi University, Nanning, China.

Na Tang (N)

The Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Guildford, Surrey, United Kingdom.
Binzhou Animal Science and Veterinary Medicine Academy & UK-China Centre of Excellence for Research on Avian Diseases, Binzhou, China.

Jun Luo (J)

Key Laboratory of Animal Immunology of the Ministry of Agriculture, Henan Provincial Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou, China.
College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.

Man Teng (M)

Key Laboratory of Animal Immunology of the Ministry of Agriculture, Henan Provincial Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou, China.

Katy Moffat (K)

The Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Guildford, Surrey, United Kingdom.

Zhiqiang Shen (Z)

Binzhou Animal Science and Veterinary Medicine Academy & UK-China Centre of Excellence for Research on Avian Diseases, Binzhou, China.

Mick Watson (M)

The Roslin Institute, R(D)SVS, University of Edinburgh, Midlothian, United Kingdom.

Venugopal Nair (V)

The Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Guildford, Surrey, United Kingdom venugopal.nair@pirbright.ac.uk yongxiu.yao@pirbright.ac.uk.
The Jenner Institute Laboratories, University of Oxford, Oxford, United Kingdom.
Department of Zoology, University of Oxford, Oxford, United Kingdom.

Yongxiu Yao (Y)

The Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Guildford, Surrey, United Kingdom venugopal.nair@pirbright.ac.uk yongxiu.yao@pirbright.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH